Although there is no report regarding association between DNMT3A polymorphisms and the outcome of AML patients, we speculate the possible mechanisms underline association between DNMT3A SNPs and chemosensitivity or disease prognosis may be explained by change in DNMT3A mRNA expression. This evidence concerns the gene DNMT3A and acute myeloid leukemia.